Canadian Journal of Gastroenterology and Hepatology

Research Article

The Cost-Effectiveness of Lenvatinib in the Treatment of Advanced or Unresectable Hepatocellular Carcinoma from a Canadian Perspective

Cost-effectiveness plane. Abbreviations: QALYs, quality-adjusted life years.